HCG Manavata is Maharashtra's first NABH-accredited cancer centre, treating 75,000+ patients annually with 65,000+ cancer surgeries performed. The centre has advanced imaging and radiotherapy for precise planning, including PET-CT, TomoTherapy-H, and Versa HD units. Dr Shruti Kate specialises in immunotherapy and targeted therapy for lung cancer, having trained at Tata Memorial Hospital. The centre's clinical research institute is audited by the US-FDA, giving access to cutting-edge clinical trials.